208 related articles for article (PubMed ID: 23837667)
1. Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: a retrospective analysis of JALSG-APL97.
Fujita H; Asou N; Iwanaga M; Hyo R; Nomura S; Kiyoi H; Okada M; Inaguma Y; Matsuda M; Yamauchi T; Ohtake S; Izumi T; Nakaseko C; Ishigatsubo Y; Shinagawa K; Takeshita A; Miyazaki Y; Ohnishi K; Miyawaki S; Naoe T;
Cancer Sci; 2013 Oct; 104(10):1339-45. PubMed ID: 23837667
[TBL] [Abstract][Full Text] [Related]
2. Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide.
Sanford D; Lo-Coco F; Sanz MA; Di Bona E; Coutre S; Altman JK; Wetzler M; Allen SL; Ravandi F; Kantarjian H; Cortes JE
Br J Haematol; 2015 Nov; 171(4):471-7. PubMed ID: 26205361
[TBL] [Abstract][Full Text] [Related]
3. Autologous hematopoietic cell transplantation for acute promyelocytic leukemia in second complete remission: outcomes before and after the introduction of arsenic trioxide.
Yanada M; Yano S; Kanamori H; Gotoh M; Emi N; Watakabe K; Kurokawa M; Nishikawa A; Mori T; Tomita N; Murata M; Hashimoto H; Henzan H; Kanda Y; Sawa M; Kohno A; Atsuta Y; Ichinohe T; Takami A
Leuk Lymphoma; 2017 May; 58(5):1061-1067. PubMed ID: 27701911
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.
Lou Y; Suo S; Tong Y; Tong H; Qian W; Meng H; Mai W; Huang J; Yu W; Jin J
Ann Hematol; 2014 Jun; 93(6):941-8. PubMed ID: 24408159
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for pediatric acute promyelocytic leukemia in Japan.
Yamamoto S; Tomizawa D; Kudo K; Hasegawa D; Taga T; Yanada M; Kondo T; Nakazawa Y; Eto T; Inoue M; Kato K; Atsuta Y; Ishida H
Pediatr Blood Cancer; 2020 May; 67(5):e28181. PubMed ID: 31965692
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective study.
Gill H; Yim R; Lee HKK; Mak V; Lin SY; Kho B; Yip SF; Lau JSM; Li W; Ip HW; Hwang YY; Chan TSY; Tse E; Au WY; Kumana CR; Kwong YL
Cancer; 2018 Jun; 124(11):2316-2326. PubMed ID: 29579321
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission: a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group.
Kohno A; Morishita Y; Iida H; Yanada M; Uchida T; Hamaguchi M; Sawa M; Sugiura I; Yamamoto K; Mizuta S; Sao H; Naoe T; Miyamura K;
Int J Hematol; 2008 Mar; 87(2):210-216. PubMed ID: 18301963
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation.
Pemmaraju N; Tanaka MF; Ravandi F; Lin H; Baladandayuthapani V; Rondon G; Giralt SA; Chen J; Pierce S; Cortes J; Kantarjian H; Champlin RE; De Lima M; Qazilbash MH
Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):485-92. PubMed ID: 23769669
[TBL] [Abstract][Full Text] [Related]
10. The role of bone marrow transplantation in acute promyelocytic leukemia.
Nabhan C; Mehta J; Tallman MS
Bone Marrow Transplant; 2001 Aug; 28(3):219-26. PubMed ID: 11535988
[TBL] [Abstract][Full Text] [Related]
11. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group.
de Botton S; Fawaz A; Chevret S; Dombret H; Thomas X; Sanz M; Guerci A; San Miguel J; de la Serna J; Stoppa AM; Reman O; Stamatoulas A; Fey M; Cahn JY; Sotto JJ; Bourhis JH; Parry A; Chomienne C; Degos L; Fenaux P
J Clin Oncol; 2005 Jan; 23(1):120-6. PubMed ID: 15534358
[TBL] [Abstract][Full Text] [Related]
12. Autologous transplant remains the preferred therapy for relapsed APL in CR2.
Ganzel C; Mathews V; Alimoghaddam K; Ghavamzadeh A; Kuk D; Devlin S; Wang H; Zhang MJ; Weisdorf D; Douer D; Rowe JM; Polge E; Esteve J; Nagler A; Mohty M; Tallman MS
Bone Marrow Transplant; 2016 Sep; 51(9):1180-3. PubMed ID: 27088379
[TBL] [Abstract][Full Text] [Related]
13. Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.
Cicconi L; Breccia M; Franceschini L; Latagliata R; Molica M; Divona M; Diverio D; Rizzo M; Ottone T; Iaccarino L; Alfonso V; Foa R; Voso MT; Lo-Coco F
Ann Hematol; 2018 Oct; 97(10):1797-1802. PubMed ID: 29951912
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran.
Alimoghaddam K; Ghavamzadeh A; Jahani M; Mousavi A; Iravani M; Rostami S; Ghaffari H; Hosseini R; Jalili M
Arch Iran Med; 2011 May; 14(3):167-9. PubMed ID: 21529103
[TBL] [Abstract][Full Text] [Related]
15. [Recurrences of acute promyelocytic leukemia in children: experience with arsenic trioxide therapy and autologous hematopoietic cell transplantation].
Baĭdil'dina DD; Maschan MA; Skorobogatova EV; Dubrovina ME; Rumiantseva IuV; Maschan AA; Rumiantsev AG; Samochatova EV
Ter Arkh; 2010; 82(7):20-5. PubMed ID: 20853604
[TBL] [Abstract][Full Text] [Related]
16. [Hematopoietic stem cell transplantation in the second or later complete remission in acute promyelocytic leukemia initially treated with all-trans retinoic acid].
Fujita H; Nakaya A; Kato J; Tachibana T; Takemura S; Hyo R; Kawano T; Tanaka M; Taguchi J; Maruta A; Fujimaki K; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2005 Oct; 46(10):1095-9. PubMed ID: 16440769
[TBL] [Abstract][Full Text] [Related]
17. Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia.
Yanada M; Tsuzuki M; Fujita H; Fujimaki K; Fujisawa S; Sunami K; Taniwaki M; Ohwada A; Tsuboi K; Maeda A; Takeshita A; Ohtake S; Miyazaki Y; Atsuta Y; Kobayashi Y; Naoe T; Emi N;
Blood; 2013 Apr; 121(16):3095-102. PubMed ID: 23412094
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
[TBL] [Abstract][Full Text] [Related]
19. Long-term survey of outcome in acute promyelocytic leukemia.
Hu J; Shen Z; Sun H; Wu W; Li X; Sun G; Wang Z
Chin Med J (Engl); 2000 Feb; 113(2):107-10. PubMed ID: 11775530
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Patients With Relapsed Acute Promyelocytic Leukemia.
Sasaki K; Ravandi F; Kadia T; DiNardo CD; Yilmaz M; Short N; Jabbour E; Patel KP; Loghavi S; Pierce S; Borthakur G; Kantarjian H
Clin Lymphoma Myeloma Leuk; 2024 Jun; 24(6):375-381. PubMed ID: 38431521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
